Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2025-09-17 00:00:00 ET · period of report 2025-09-15 · accession 0001437749-25-029226 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-09-17 | 2025-09-15+ | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | P - Purchase | $0.7853 | +4,117 | 110.6K | +4% | +$3,233 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-16 | P | A | 1,617 | $0.84 | 112,174 | D | — | — | (F1) Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants. |
| 2 | Common | Common Stock | 2025-09-15 | P | A | 2,500 | $0.75 | 110,557 | D | — | — | (F1) Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants. |